A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL® capsules) with MST Continus® tablets in cancer patients with severe pain

Palliative Medicine

Volumn 11, Issue 6, 1997, Pages 475-482

  O'Brien, T ^a,c   Mortimer, P G ^b   McDonald, C J ^b   Miller, A J ^b  

^a Marymount Hospice ^*  (Ireland)

^b Napp Laboratories   (United Kingdom)

^c ST PATRICK S HOSPITAL   (Ireland)

Author keywords

Drug compounding; Morphine; Pain; Palliative care; Therapeutic equivalence

Indexed keywords

MORPHINE; MORPHINE SULFATE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG PREFERENCE; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0030700336     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921639701100608     Document Type: Article

References (15)

1. Dorrepaal KL et al. Pain experience and pain management among hospitalized cancer patients. A clinical study. Cancer 1989; 63: 593-98.
2. Twycross RG, ed. Cancer pain: a global perspective. The Edinburgh symposium on pain control and medical education. Royal Society of Medicine International Congress and Symposium Series No. 149: 3-16, 1989.
3. Schug SA, Zech D, Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage 1990; 5: 27-32.
4. World Health Organization. Cancer pain relief. Geneva: WHO, 1986.
5. Schauer PK, Agostinucci W, Gannon R, Schauer AR. Practical aspects of pain management in cancer patients. Conn Med 1989; 53: 211-15.
6. Brooks I, De Jager R, Blumenreich M, George E, Savarese JJ. Principles of cancer pain management - use of long term oral morphine. J Fam Pract 1989; 28: 275-80.
7. Twycross RG. Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv 1988; 7: 29-53.
8. Lamerton RC. Evaluation of MST Continus Tablets 60 mg and 100 mg in the treatment of pain in terminal illness - a hospice overview. In: Wilkes E ed. Advances in morphine therapy. The 1983 international symposium on pain control. Royal Society of Medicine International Congress and Symposium Series No. 64, 1984: 85-89.
9. Goughnour B, Arkinstall W, Stewart J, White J. Plasma morphine levels and analgesic response following single oral doses of sustained release morphine tablets and oral morphine solution. In: Band P, Stewart J, Towson T eds. Advances in the management of chronic pain. The international symposium on pain control. Toronto: Purdue Frederick, 1986: 93-99.
10. Arkinstall W, Goughnour B, Stewart J, White J. Double-blind comparison between sustained release morphine tablets and oral morphine solution in patients with severe pain: a preliminary report. In: Band P, Stewart J, Towson T eds. Advances in the management of chronic pain. The international symposium on pain control Toronto: Purdue Frederick, 1986: 51-56.
11. Ferrell B, Wisdom C, Wenzl C, Brown J. Effects of controlled-release morphine on quality of life for cancer pain. Oncol Nurs Forum 1989; 16: 521-26.
12. Smith KJ, Miller AJ, Sinclair KA et al. A novel once-daily morphine preparation: pharmacokinetic development. Proceedings of the eighth world congress on pain. Vancouver: International Association for the Study of Pain, 1996.
13. Whitehead J. The design and analysis of sequential clinical trials. Hemel Hempstead: Ellis Horwood, 1992.
14. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972; 28: 577-84.
15. McGettrick S, Rodgers J. Cost of administering controlled drugs in a hospice ward. Health Bulletin 1996; 54: 441-42.